Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance · Aug 12, 2026 · Medicus Pharma Ltd. Warrant (MDCXW)
Company Highlights Significant Regulatory, Clinical and Strategic Progress Across SkinJect® and Teverelix® Programs and a Strengthened Financial Position Supporting Continued Pipeline Execution and Expansion PHILADELPHIA, PA / ACCESS Newswire ...
Not investment advice. Cached headline, not a full reprint.